Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
2 hedge funds and large institutions have $10.1M invested in Motif Bio plc ADRs in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
18% more capital invested
Capital invested by funds: $8.51M → $10.1M (+$1.57M)
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$310 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$129K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
MTFB Hedge Fund Activity: Q3 2017 in Review
2 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q3 2017, worth a combined $10.1M — up 18% from $8.51M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of MTFB and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $310. The largest seller was Jane Street, exiting entirely with an estimated $129K sold.
- 2 institutional investors held Motif Bio plc ADRs (MTFB) as of Q3 2017, down from 4 in Q2 2017.
- Funds reported $10.1M of Motif Bio plc ADRs stock for Q3 2017, up 18% quarter-over-quarter.
- 1 fund opened new Motif Bio plc ADRs positions in Q3 2017 and 3 closed out, a net change of -2 holders.
- The largest Motif Bio plc ADRs buyer in Q3 2017 was Bank of America, an estimated $310 added.
- The largest Motif Bio plc ADRs seller in Q3 2017 was Jane Street, an estimated $129K sold.
Based on aggregated 13F filings for Q3 2017.